Prediction of Stroke Risk in Patients with Atrial Fibrillation Based on Chest CT Images
Launched by FIRST AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY · Sep 22, 2024
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study how we can predict the risk of stroke in patients with a heart condition called atrial fibrillation (AF). Researchers want to use advanced computer technology to analyze chest CT images of the heart, focusing on a specific part called the left atrial appendage. They will combine this information with other health data to see if they can better identify which patients are at a higher risk for having a stroke. The study will involve patients who have been diagnosed with AF but do not have issues related to heart valve problems.
To be eligible for this trial, patients must have a confirmed diagnosis of atrial fibrillation and must have accessible chest CT images along with complete medical records. Those who have had certain heart procedures or whose CT images are of poor quality will not be included. Participants can expect to contribute to important research that could help improve stroke prevention in the future. The trial is currently not recruiting patients, so there will be no immediate participation opportunities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with atrial fibrillation by ECG, 24-hour Holter monitor, or recordable ECG monitor; atrial fibrillation confirmed by an implanted pacemaker or defibrillator, lasting at least 30 seconds Available chest CT images and complete clinical data.
- Exclusion Criteria:
- • Incomplete clinical data or diagnosis of valvular atrial fibrillation (e.g., rheumatic heart valve disease, post-valve replacement) Poor-quality CT images that prevent complete assessment of left atrial appendage morphology Patients who have undergone left atrial appendage closure Patients who have had radiofrequency ablation or cardioversion with no evidence of recurrence post-procedure
About First Affiliated Hospital Of Zhejiang University
The First Affiliated Hospital of Zhejiang University is a leading medical institution located in Hangzhou, China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive network of specialists and state-of-the-art facilities to facilitate groundbreaking studies across various medical disciplines. With a focus on improving patient outcomes and contributing to global medical knowledge, the hospital actively engages in collaborative research initiatives, ensuring rigorous adherence to ethical standards and regulatory compliance. Its dedication to fostering a culture of scientific inquiry underscores its role as a pivotal player in the advancement of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported